Works matching IS 03407004 AND DT 2020 AND VI 69 AND IP 5

Results: 19

Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 683, doi. 10.1007/s00262-020-02543-6

By:

Kerepesi, Csaba;
Bakacs, Tibor;
Moss, Ralph W.;
Slavin, Shimon;
Anderson, Colin C.

Publication type:

Article

Current progress in NK cell biology and NK cell-based cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 879, doi. 10.1007/s00262-020-02532-9

By:

Tarazona, Raquel;
Lopez-Sejas, Nelson;
Guerrero, Beatriz;
Hassouneh, Fakhri;
Valhondo, Isabel;
Pera, Alejandra;
Sanchez-Correa, Beatriz;
Pastor, Nieves;
Duran, Esther;
Alonso, Corona;
Solana, Rafael

Publication type:

Article

Co-expression of HLA-I loci improved prognostication in HER2+ breast cancers.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 799, doi. 10.1007/s00262-020-02512-z

By:

Tsang, Julia Y.;
Ho, Chun-Sing;
Ni, Yun-Bi;
Shao, Yan;
Poon, Ivan K.;
Chan, Siu-Ki;
Cheung, Sai-Yin;
Shea, Ka-Ho;
Marabi, Monalyn;
Tse, Gary M.

Publication type:

Article

Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 813, doi. 10.1007/s00262-020-02513-y

By:

Risnik, Denise;
Colado, Ana;
Podaza, Enrique;
Almejún, María Belén;
Elías, Esteban Enrique;
Bezares, Raimundo Fernando;
Fernández-Grecco, Horacio;
Seija, Noé;
Oppezzo, Pablo;
Borge, Mercedes;
Gamberale, Romina;
Giordano, Mirta

Publication type:

Article

LincRNA-p21 knockdown reversed tumor-associated macrophages function by promoting MDM2 to antagonize* p53 activation and alleviate breast cancer development.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 835, doi. 10.1007/s00262-020-02511-0

By:

Zhou, Lining;
Tian, Yu;
Guo, Fang;
Yu, Bin;
Li, Jiali;
Xu, Huaxi;
Su, Zhaoliang

Publication type:

Article

Human inflammatory dendritic cells in malignant pleural effusions induce Th1 cell differentiation.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 779, doi. 10.1007/s00262-020-02510-1

By:

Gu, Fei-fei;
Wu, Jing-jing;
Liu, Yang-yang;
Hu, Yue;
Liang, Jin-yan;
Zhang, Kai;
Li, Ming;
Wang, Yan;
Zhang, Yong-an;
Liu, Li

Publication type:

Article

Activation of TLR4 signaling inhibits progression of osteosarcoma by stimulating CD8-positive cytotoxic lymphocytes.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 745, doi. 10.1007/s00262-020-02508-9

By:

Yahiro, Kenichiro;
Matsumoto, Yoshihiro;
Yamada, Hisakata;
Endo, Makoto;
Setsu, Nokitaka;
Fujiwara, Toshifumi;
Nakagawa, Makoto;
Kimura, Atsushi;
Shimada, Eijiro;
Okada, Seiji;
Oda, Yoshinao;
Nakashima, Yasuharu

Publication type:

Article

Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 847, doi. 10.1007/s00262-020-02498-8

By:

Noguchi, Masanori;
Arai, Gaku;
Egawa, Shin;
Ohyama, Chikara;
Naito, Seiji;
Matsumoto, Kazumasa;
Uemura, Hirotsugu;
Nakagawa, Masayuki;
Nasu, Yasutomo;
Eto, Masatoshi;
Suekane, Shigetaka;
Sasada, Tetsuro;
Shichijo, Shigeki;
Yamada, Akira;
Kakuma, Tatsuyuki;
Itoh, Kyogo

Publication type:

Article

Nonlinear response to cancer nanotherapy due to macrophage interactions revealed by mathematical modeling and evaluated in a murine model via CRISPR-modulated macrophage polarization.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 731, doi. 10.1007/s00262-020-02504-z

By:

Leonard, Fransisca;
Curtis, Louis T.;
Hamed, Ahmed R.;
Zhang, Carolyn;
Chau, Eric;
Sieving, Devon;
Godin, Biana;
Frieboes, Hermann B.

Publication type:

Article

The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 703, doi. 10.1007/s00262-020-02503-0

By:

Rosenbaum, Pierre;
Artaud, Cécile;
Bay, Sylvie;
Ganneau, Christelle;
Campone, Mario;
Delaloge, Suzette;
Gourmelon, Carole;
Loirat, Delphine;
Medioni, Jacques;
Pein, François;
Sablin, Marie-Paule;
Tredan, Olivier;
Varga, Andrea;
Leclerc, Claude

Publication type:

Article

CD160 expression on CD8+ T cells is associated with active effector responses but limited activation potential in pancreatic cancer.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 789, doi. 10.1007/s00262-020-02500-3

By:

Liu, Songyang;
Zhang, Wei;
Liu, Kai;
Wang, Yingchao

Publication type:

Article

CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 825, doi. 10.1007/s00262-020-02486-y

By:

Pan, Qiu-Zhong;
Liu, Qing;
Zhou, Yu-Qing;
Zhao, Jing-Jing;
Wang, Qi-Jing;
Li, Yong-Qiang;
Tang, Yan;
Gu, Jia-Mei;
He, Jia;
Chen, Shi-Ping;
Weng, De-Sheng;
Xia, Jian-Chuan

Publication type:

Article

Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 771, doi. 10.1007/s00262-020-02506-x

By:

Hurkmans, Daan P.;
Kuipers, Merian E.;
Smit, Jasper;
van Marion, Ronald;
Mathijssen, Ron H. J.;
Postmus, Piet E.;
Hiemstra, Pieter S.;
Aerts, Joachim G. J. V.;
von der Thüsen, Jan H.;
van der Burg, Sjoerd H.

Publication type:

Article

Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 717, doi. 10.1007/s00262-020-02497-9

By:

Kasanen, Henna;
Hernberg, Micaela;
Mäkelä, Siru;
Brück, Oscar;
Juteau, Susanna;
Kohtamäki, Laura;
Ilander, Mette;
Mustjoki, Satu;
Kreutzman, Anna

Publication type:

Article

"Tumor immunology meets oncology (TIMO) XV", April 25th–27th 2019, Halle/Saale, Germany.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 901, doi. 10.1007/s00262-020-02491-1

By:

Steven, André;
Massa, Chiara;
Seliger, Barbara

Publication type:

Article

Talimogene laherparepvec treatment to overcome loco-regional acquired resistance to immune checkpoint blockade in tumor stage IIIB–IV M1c melanoma patients.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 759, doi. 10.1007/s00262-020-02487-x

By:

Fröhlich, Anne;
Niebel, Dennis;
Fietz, Simon;
Egger, Eva;
Buchner, Andrea;
Sirokay, Judith;
Landsberg, Jennifer

Publication type:

Article

Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 689, doi. 10.1007/s00262-020-02499-7

By:

Nukui, Akinori;
Kamai, Takao;
Arai, Kyoko;
Kijima, Toshiki;
Kobayashi, Minoru;
Narimatsu, Takahiro;
Kambara, Tsunehito;
Yuki, Hideo;
Betsunoh, Hironori;
Abe, Hideyuki;
Fukabori, Yoshitatsu;
Yashi, Masahiro;
Yoshida, Ken-Ichiro

Publication type:

Article

New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 867, doi. 10.1007/s00262-020-02484-0

By:

Jordaens, Stephanie;
Cooksey, Leah;
Freire Boullosa, Laurie;
Van Tendeloo, Viggo;
Smits, Evelien;
Mills, Ken I.;
Orchard, Kim H.;
Guinn, Barbara-ann

Publication type:

Article

Long-term surviving cancer patients as a source of therapeutic TCR.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 859, doi. 10.1007/s00262-019-02468-9

By:

Inderberg, Else Marit;
Wälchli, Sébastien

Publication type:

Article